CinFina Pharma Announces FDA Clearance of Investigational New Drug Application and First Participants Dosed in Phase 1 Trial of CIN-110 for the Treatment of Obesity
![](https://cinrx.com/wp-content/uploads/2022/09/cinfina-tile.jpg)
CinFina Pharma Announces FDA Clearance of Investigational New Drug Application and First Participants Dosed in Phase 1 Trial of CIN-110 for the Treatment of Obesity
CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise
![](https://cinrx.com/wp-content/uploads/2022/09/cinfina-tile.jpg)
CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise.
CinRx Pharma Announces Gavin Samuels as Chief Business Officer
![](https://cinrx.com/wp-content/uploads/2022/10/web-tile-500x200-1.png)
CinRx Pharma announced today that Gavin Samuels, M.D., M.B.A has assumed the role of Chief Business Officer.